PLUS THERAPEUTICS, INC. — Director's Dealing 2021

Feb 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2021-02-16

Reporting Person: HEDRICK MARC H (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-16	Stock Option (right to buy)	$3.64	A	88314	Acquired	2031-02-16	Common Stock (88314)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.